Peritonitis caused by Ewingella americana in a patient with peritoneal dialysis: a case report

Li Li, Jianxiong Shen, Jianmin Tao

  • 1Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, No,110, Ganhe road, Shanghai 200437, China. yyyylab@126.com.

Abstract

Insights

Peritonitis in continuous ambulatory peritoneal dialysis patients can be caused by Ewingella americana, not just Staphylococcus aureus. This rare pathogen requires specific antibiotic considerations for effective treatment.

Area of Science:

  • Nephrology
  • Infectious Diseases
  • Microbiology

Background:

  • Peritonitis is a common complication in patients undergoing continuous ambulatory peritoneal dialysis (CAPD).
  • Staphylococcus aureus is the typical causative agent, guiding empiric antibiotic selection.
  • This case highlights a less common etiology, Ewingella americana, necessitating alternative treatment strategies.

Purpose of the Study:

  • To report a case of CAPD-associated peritonitis caused by Ewingella americana.
  • To emphasize the distinct antibiotic susceptibility profile of E. americana compared to common pathogens.
  • To inform treatment considerations for CAPD peritonitis when unusual bacteria are involved.

Main Methods:

  • A case presentation of a 76-year-old female patient with chronic renal failure on CAPD.
  • Microbiological examination to identify the causative pathogen.
  • Analysis of the identified pathogen's antibiotic susceptibility.
  • Clinical observation of treatment response to antibiotic modification.

Main Results:

  • The patient presented with generalized abdominal pain, indicative of peritonitis.
  • Ewingella americana was identified as the causative pathogen.
  • The pathogen exhibited a different antibiotic susceptibility pattern compared to typical CAPD peritonitis organisms.
  • Switching antibiotic therapy from vancomycin to amikacin led to accelerated recovery.

Conclusions:

  • Ewingella americana can cause peritonitis in CAPD patients, expanding the spectrum of known causative agents.
  • The unique antibiotic susceptibility of E. americana requires careful consideration in empiric and targeted therapy.
  • This case underscores the importance of microbiological diagnosis and tailored antibiotic selection for CAPD-related peritonitis.

Related Concept Videos

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
2.1K
Peritoneal Dialysis III: Nursing Management01:25

Peritoneal Dialysis III: Nursing Management

Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
1.6K
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
1.1K
Peritoneal Dialysis I: Introduction and Procedure01:30

Peritoneal Dialysis I: Introduction and Procedure

Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...
8.5K
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
842
Acute Pyelonephritis I: Introduction01:27

Acute Pyelonephritis I: Introduction

Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such...
1.5K